Vascular Endothelial Growth Factor Improves Liver Regeneration and Survival after 90% Hepatectomy in a Rat Model of Diet-Induced Steatosis

Abstract

Background/Aims: Fatty liver disease increases the risk in major liver resection for patients. As previous studies suggested that vascular endothelial growth factor (VEGF) and erythropoietin (EPO) might improve liver regeneration in nonobese animals, we investigated their effect after subtotal hepatectomy (SH) in rats with diet-induced steatosis. Methods: Male Wistar rats were fed with fatty liver-inducing diet (FLD) or normal diet (control) for 11-12 weeks followed by 90% SH. Animals were treated either with EPO, VEGF or NaCl on postoperative days 0, 1 and 3 and sacrificed 24 h or 7 days after SH. Survival rate, liver regeneration and biochemical markers were assessed. Expression of inflammatory cytokines (TNF-α, IL-6) and apoptosis-related genes (PUMA, Bcl-2) was measured by qRT-PCR. Results: Seven-day survival after SH was significantly decreased in the FLD group compared to controls (50 vs. 100%, p < 0.05). In FLD animals, treatment with VEGF increased 7-day survival to 90% compared to only 40% in the EPO group. After surgery, blood glucose levels of VEGF but not EPO- or NaCl-treated animals remained normal. Inflammatory genes were markedly upregulated in the EPO group 24 h after SH. Conclusions: Steatosis severely impairs survival and regeneration after extensive liver resection, which can be counteracted at least in part by perioperative treatment with VEGF.

Novel Benefits of Remote Ischemic Preconditioning Through VEGF-dependent Protection From Resection-induced Liver Failure in the Mouse

“…Intriguingly, exogenous VEGF can improve liver regeneration also in a steatotic or cirrhotic background. [18][19][20] These findings imply that (i) RIPC may be substituted through VEGF delivery to achieve more targeted benefits, and that (ii) RIPC/VEGF might be beneficial also in a background of liver disease.…”

Hallmarks of postoperative liver regeneration: An updated insight on the regulatory mechanisms

“…Current potential therapeutic strategies focus on administration of exogeneous hormones, cytokines, growth factors, and chemokines, including EGF, HGF, and vascular endothelial growth factor, and fibroblast growth factor . Preclinical animal experiments suggest that this may stimulate liver regeneration, prevent hepatic failure, and increase postoperative survival .…”

The Role of Adipokines in Surgical Procedures Requiring Both Liver Regeneration and Vascular Occlusion

“…Nonetheless, regeneration which is inherent to the liver after certain surgical procedures and the mechanism of damage caused by the removal of hepatic mass and those associated with cold I/R should be considered when SFS are transplanted. Indeed, patients transplanted with SFS grafts appear to have a poorer prognosis after transplantation, and the regeneration of liver is markedly inhibited leading to compromised liver function and graft loss [ 4 , 77 ].…”